RBM18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.289800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.595800E-01
Normal-vs-Stage2
7.429600E-01
Normal-vs-Stage3
1.554560E-01
Normal-vs-Stage4
3.868600E-01
Stage1-vs-Stage2
4.234200E-01
Stage1-vs-Stage3
1.863450E-01
Stage1-vs-Stage4
5.061000E-01
Stage2-vs-Stage3
1.924440E-01
Stage2-vs-Stage4
8.750000E-02
Stage3-vs-Stage4
4.888100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.084400E-01
Normal-vs-AfricanAmerican
7.954000E-01
Normal-vs-Asian
6.673400E-01
Caucasian-vs-AfricanAmerican
3.988800E-01
Caucasian-vs-Asian
6.367400E-01
AfricanAmerican-vs-Asian
3.960600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.786800E-01
Normal-vs-Female
8.941200E-01
Male-vs-Female
6.226000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.573200E-01
Normal-vs-Age(41-60Yrs)
7.096200E-01
Normal-vs-Age(61-80Yrs)
6.164400E-01
Normal-vs-Age(81-100Yrs)
3.585400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.214200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.996400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.009600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.039800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.920400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.759600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.250000E-01
Normal-vs-Daily Drinker
4.440200E-01
Normal-vs-Weekly Drinker
4.078000E-01
Normal-vs-Occasional Drinker
9.184800E-01
Normal-vs-Social Drinker
7.041200E-01
Non Drinker-vs-Daily Drinker
6.858800E-01
Non Drinker-vs-Weekly Drinker
7.796600E-01
Non Drinker-vs-Occasional Drinker
4.739600E-02
Non Drinker-vs-Social Drinker
6.306300E-02
Daily Drinker-vs-Weekly Drinker
9.404800E-01
Daily Drinker-vs-Occasional Drinker
1.293840E-01
Daily Drinker-vs-Social Drinker
1.021760E-01
Weekly Drinker-vs-Occasional Drinker
1.600030E-01
Weekly Drinker-vs-Social Drinker
1.016430E-01
Occasional Drinker-vs-Social Drinker
5.201800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.906600E-01
Normal-vs-Grade 2
1.198850E-01
Normal-vs-Grade 3
1.475360E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.123200E-01
Grade 1-vs-Grade 3
6.123400E-01
Grade 1-vs-Grade 4
2.906600E-01
Grade 2-vs-Grade 3
7.773200E-01
Grade 2-vs-Grade 4
1.198850E-01
Grade 3-vs-Grade 4
1.475360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.411200E-01
Normal-vs-NonDiabetic
7.746600E-01
Diabetic-vs-NonDiabetic
3.864800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.076000E-01
Normal-vs-NoPancreatitis
7.896000E-01
Pancreatitis-vs-NoPancreatitis
8.534400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.525400E-01
Normal-vs-N1
7.623400E-01
N0-vs-N1
5.581600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.794200E-01
Normal-vs-TP53-NonMutant
8.952600E-01
TP53-Mutant-vs-TP53-NonMutant
5.856400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
